dendritic cell vaccine (Medistem/Genelux/University of California/San Diego State University)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namedendritic cell vaccine (Medistem/Genelux/University of California/San Diego State University)
Drug Alias NameN/A
ClassificationBiologics > Antigen > Tumor antigenVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapy +[4] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedistem Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSan Diego State UniversityMedistem IncUniversity Of California +[4] 
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A